CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Learn what questions to ask a financial advisor as a new investor. Empower yourself with the right information for success.
27,223 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Tech stocks swung wildly midday as traders dumped riskier names, then rotated into consumer staples and paints. By da...
A fresh look at why a trillion-dollar cloud leader could outpace Apple in AI. Learn the mechanics, risks, and how to ...
AI is accelerating the pace at which startups reach unicorn status, with policy shifts and market volatility adding c...
A new financing concept could use Airbnb’s scale to support host loans without adding inventory on the company’s book...
CECO (CECO) 2025 earnings will hinge on project backlogs, margins, and demand for air quality and energy solutions. T...
Mattel announces a bold 2026 transformation to become an IP-driven entertainment platform, deploying $150 million for...
XRP rose roughly 7% after a delay in Iranian strikes ordered by Donald Trump, lifting the token to around $1.46. The ...
The Senate Banking Committee is set to vote on the Clarity Act this week, a move that could reshape crypto regulation...
South Carolina passed a landmark bill banning central bank digital currencies and guaranteeing tax neutrality for dig...
Investors are watching Ambarella’s path to 2027 with a focus on growth drivers, margins, and the long-term AI camera ...
A U.S.-based drone parts supplier sparked a notable stock move as analysts adjusted targets and policy shifts tighten...